Avanos Medical (NYSE:AVNS) Releases Earnings Results, Beats Estimates By $0.07 EPS

Avanos Medical (NYSE:AVNS) released its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.07, Zacks reports. The firm had revenue of $167.50 million for the quarter, compared to analysts’ expectations of $161.75 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The company’s revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter last year, the business posted $0.22 earnings per share. Avanos Medical updated its FY 2025 guidance to 0.750-0.950 EPS.

Avanos Medical Stock Performance

NYSE AVNS opened at $12.59 on Thursday. The stock has a market capitalization of $579.27 million, a price-to-earnings ratio of 37.04 and a beta of 1.13. Avanos Medical has a twelve month low of $11.84 and a twelve month high of $25.36. The stock has a 50-day moving average of $13.53 and a 200 day moving average of $16.21. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a report on Wednesday, March 19th.

Insiders Place Their Bets

In other news, SVP Kerr Holbrook sold 7,000 shares of Avanos Medical stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares of the company’s stock, valued at approximately $1,251,216.75. The trade was a 7.86 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.64% of the stock is currently owned by corporate insiders.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.